Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

G3BP1 inhibits Cul3<sup>SPOP</sup> to amplify AR signaling and promote prostate cancer.

Nature communications·2021
Same author

Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer.

European urology oncology·2021
Same author

Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimen.

Urologic oncology·2021
Same author

Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate Cancer.

Nature cancer·2021
Same author

Epigenetically defined therapeutic targeting in H3.3G34R/V high-grade gliomas.

Science translational medicine·2021
Same author

Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas.

Science translational medicine·2021

Related Experiment Video

Updated: Jul 15, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Feature selection and molecular classification of cancer using genetic programming.

Jianjun Yu1, Jindan Yu, Arpit A Almal

  • 1Bioinformatics Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA.

Neoplasia (New York, N.Y.)
|April 27, 2007
PubMed
Summary

Genetic programming (GP) effectively identifies key genes for cancer classification, creating simple, accurate diagnostic tools. These genetic programming classifiers perform well across different studies and platforms.

More Related Videos

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

Related Experiment Videos

Last Updated: Jul 15, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

Area of Science:

  • Bioinformatics
  • Machine Learning
  • Cancer Genomics

Background:

  • Microarray-based tumor classification faces challenges in identifying robust biomarkers and practical gene sets for clinical use.
  • Current analysis programs often struggle to develop classifiers with a limited number of genes.

Purpose of the Study:

  • To apply genetic programming (GP) for feature gene selection and molecular classifier development in cancer expression profiling data.
  • To assess the robustness, accuracy, and clinical applicability of GP-generated classifiers.

Main Methods:

  • Utilized genetic programming (GP), an evolutionary algorithm, to analyze cancer expression profiling data.
  • Generated thousands of GP classifiers to identify discriminative feature genes and build predictive models.
  • Evaluated GP classifier performance on independent datasets and compared with conventional methods.

Main Results:

  • GP identified a consistent set of highly discriminative, disease-associated genes.
  • GP classifiers, often with five or fewer genes, accurately predicted cancer types and subtypes.
  • Classifiers demonstrated predictive power on independent studies using different microarray platforms.
  • GP achieved classification accuracy comparable to or better than conventional methods.

Conclusions:

  • Genetic programming offers a valuable approach for developing effective cancer diagnostic and prognostic classifiers.
  • GP generates classifiers with a practical, limited set of genes, enhancing clinical utility.
  • The mathematical nature of GP classifiers provides insights into gene relationships.